• Facets (new session)
• Description
• Metadata
• Settings
  • Rule: ActivityStreamsMapasEquivalentb3sb3sifpdbprdf-labelfacetshttp://dbpedia.org/resource/inference/rules/dbpedia#http://dbpedia.org/resource/inference/rules/opencyc#http://dbpedia.org/resource/inference/rules/umbel#http://dbpedia.org/resource/inference/rules/yago#http://dbpedia.org/schema/property_rules#http://www.ontologyportal.org/inference/rules/SUMO#http://www.ontologyportal.org/inference/rules/WordNet#http://www.w3.org/2002/07/owl#ldpoplwebskos-transurn:det:rdf:labelvirtrdf-labelvirtrdf-urlNone
    
  • Inverse Functional Properties: Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects
  • "Same As": Disabled (fastest) Apply to subjects only Apply to objects only Apply to both subjects and objects (recommended) Apply to subjects, objects and predicates (not recommended on big datasets) Apply to predicates only (special use cases only)

About: Brett Giroir     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : yago:Whole100003553, within Data Space : dbpedia.org associated with source document(s)

Type: Thingfoaf:Personpersondul:NaturalPersonEukaryotePersonHumanAnimalPoliticianyago:WikicatBiomedicalResearchersanimaleukaryotespeciesschema:Personyago:WikicatLivingPeopleyago:WikicatPeopleFromJeffersonParish,Louisianayago:Alumnus109786338yago:CausalAgent100007347yago:Intellectual109621545yago:LivingThing100004258yago:Object100002684yago:Organism100004475yago:Person100007846yago:PhysicalEntity100001930yago:ResearchWorker110523076yago:WikicatHarvardUniversityAlumniyago:YagoLegalActoryago:YagoLegalActorGeopoliticianyago:Scholar110557854yago:Scientist110560637yago:Whole100003553 New Facet based on Instances of this Class

Brett P. Giroir (pronounced jir-WAH) (born November 4, 1960) is an American pediatrician and a former four-star admiral in the U.S. Public Health Service Commissioned Corps. Dr. Giroir currently serves as CEO and a member of the Board of Directors for Altesa BioSciences, Inc, a clinical stage biopharmaceutical company focusing on developing new treatments for respiratory viruses and global viral threats. He is also a co-founder and independent director for Revelar Biotherapeutics, and an independent director for OncoNano Medicine. His non-profit activities include Board service on the Global Virus Network and Remote Area Medical (RAM), and he remains active in global humanitarian initiatives in Latin America and Sub-Saharan Africa. He previously served as the 16th assistant secretary fo